Alpha Growth plc
("Alpha" or the "Company")
Change of Accounting Reference Date
Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in life insurance-linked wealth and asset management, announces that it has changed its year end to 31 March 2025. Accordingly, the next audited financial statements for the Company will be prepared for the 15-month period ending 31 March 2025 and will be required to be released by 31 July 2025.
The Directors have determined that this change will provide the incoming auditors with sufficient time to complete their on-boarding process and plan for the upcoming audit. Directors also believe that moving away from a calendar year-end will mean that the auditors will avoid the traditional calendar year end audit pressures and be able to allocate sufficient resources to the Company and its subsidiaries.
In accordance with the Listing Rules, the Company will issue a set of unaudited interim financials covering the 12-month period to 31 December 2024, on or before 31 March 2025.
** ENDS **
For more information, please visit www.algwplc.com or contact the following:
Alpha Growth plc |
+44 (0) 20 3959 8600 |
Gobind Sahney, Executive Chairman |
|
Allenby Capital Limited |
+44 (0) 20 3328 5656 |
Amrit Nahal (Sales and Corporate Broking) |
|
Nick Athanas / Piers Shimwell (Corporate Finance) |
|
UK Investor Relations - Mark Treharne |
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.
Longevity Assets and Non-correlation
As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.
Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.
Forward Looking Statements Disclaimer
Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.
Important Notice
The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.